Cynata Therapeutics Ltd
ASX:CYP
Cynata Therapeutics Ltd
ASX:CYP
Price:
0.011
AUD
-15.38%
Market Closed
Market Cap:
AU$2.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
Intrinsic Value
Not Available for CYP
There is not enough data to reliably calculate the intrinsic value for Cynata Therapeutics Ltd.
Do our valuations actually work? See backtest results .
Alternatives to CYP
Fundamental Analysis
What Cynata Therapeutics Does
Cynata Therapeutics is a biotech company that develops cell-based medicines, mainly therapies built from mesenchymal stem cells, or MSCs. Its core idea is to make these cells from a master cell line rather than relying on donors one batch at a time. That matters because it is meant to give drug developers a more consistent and scalable source of cells for testing and treatment.
- Headquarters
- Australia AU
- IPO date
- Dec 20, 2007
Financials
Efficiency
Earnings Waterfall
Cynata Therapeutics Ltd
Cynata Therapeutics Ltd